will a doctor prescribe semaglutide for weight loss The push Medicare to cover weight-loss drugs: An explainer Medical Weight Loss

Patients taking the medication have reduced appetite, and when they do eat, they feel full sooner, he noted

Methylcobalamin provides immediate bioavailability without requiring metabolic conversion, making it theoretically superior

Supports glucose & carbs metabolism

doi:10.1080/10408398.2018.1511967

Key Takeaways Triple agonist mechanism: Retatrutide is the first medication to activate GIP, GLP-1, and glucagon receptors simultaneously GLP-1 component reduces appetite and slows gastric emptying, the core appetite suppression pathway GIP component improves insulin sensitivity and promotes favorable fat distribution Glucagon component increases energy expenditure through thermogenesis and promotes fat breakdown Weight loss: Phase 2 trials showed up to 24.2% weight loss at 48 weeks, compared to tirzepatide (~22%) and semaglutide (~15%) Investigational status: Not FDA-approved